Keyphrases
Denmark
100%
COVID-19
66%
Community-acquired Pneumonia
50%
Confidence Interval
44%
National Cohort Study
43%
Chronic Obstructive Pulmonary Disease
37%
Hospitalized Patients
31%
Prospective Cohort Study
22%
Hospitalization
21%
Randomized Controlled Trial
21%
People Living with HIV (PLHIV)
19%
Tuberculosis
17%
Meningitis
16%
Risk Factors
15%
Incidence Rate
15%
Antipyrine
15%
Hazard Ratio
14%
Retrospective Cohort Study
13%
Comorbidity
13%
Acute Exacerbation of COPD (AECOPD)
12%
Bacterial Meningitis
12%
All-cause Mortality
12%
Patients with COVID-19
12%
Health-related Quality of Life
11%
Observational Cohort Study
11%
Cerebrospinal Fluid
11%
Odds Ratio
11%
Inhaled Corticosteroids
10%
Antibiotic Treatment
10%
Invasive Pneumococcal Disease
10%
Solid Organ Transplant Recipients
9%
AIDS/HIV
9%
Pneumonia
9%
Relative Risk
9%
SARS-CoV-2 Infection
9%
Infectious Diseases
8%
Remdesivir
8%
Non-specific Symptoms
8%
Severe Chronic Obstructive Pulmonary Disease
8%
Lung Cancer
8%
30-day Mortality
8%
Pulmonary Rehabilitation
8%
Mortality Risk
8%
Antibiotics
8%
Quality of Life
8%
In-tube
7%
Hepatitis C Virus
7%
Patient Experience
7%
Metronidazole
7%
Herpes Simplex Virus 2 (HSV-2)
7%
C-reactive Protein
7%
Unfavorable Outcome
7%
Hospital Admission
7%
Metabolism
7%
Dyspnea
7%
Clinical Outcomes
7%
COVID-19 Pandemic
7%
Lung Cancer Screening
7%
Placebo
7%
HIV Patients
7%
Vaccination
7%
Pseudomonas Aeruginosa (P. aeruginosa)
7%
Readmission
7%
Mycobacterium Tuberculosis (M. tb)
7%
QuantiFERON
7%
Central Nervous System Infections
7%
Adiponectin
6%
Adult Patients
6%
Mortality Rate
6%
Cimetidine
6%
Chronic Hepatitis C
6%
HIV Infection
6%
Cancer Diagnosis
6%
Azithromycin
6%
Brain Abscess
6%
Glasgow Outcome Scale
6%
Hospitalized COVID-19 Patients
6%
Non-associated
6%
Continuous Glucose Monitoring
6%
Oxazepam
6%
Hydroxychloroquine
6%
High-risk Human Papillomavirus (HR-HPV)
6%
Hepatitis C
6%
Interferon-gamma Release Assay
6%
Diabetes
6%
High Risk
5%
Obesity
5%
Healthy Individuals
5%
Immunocompromised Patients
5%
Antibiotic Therapy
5%
Short Course
5%
Hepatitis B Virus
5%
Immune Response
5%
Streptococcus Pneumoniae
5%
Varicella Zoster Virus
5%
At Discharge
5%
Mortality Prediction
5%
Length of Stay
5%
COPD Patients
5%
Capital Region
5%
Medicine and Dentistry
Cohort Analysis
65%
Infection
52%
COVID-19
47%
Community-Acquired Pneumonia
41%
Chronic Obstructive Pulmonary Disease
39%
Human Immunodeficiency Virus
28%
Severe Acute Respiratory Syndrome Coronavirus 2
26%
Disease
25%
Prospective Cohort Study
19%
Randomized Controlled Trial
18%
Bacterial Meningitis
13%
Meningitis
12%
Prevalence
12%
Antibiotic Therapy
12%
Symptom
11%
Retrospective Cohort Study
11%
Quality of Life
11%
Hazard Ratio
11%
Biological Marker
10%
Antibiotics
10%
Cohort Study
10%
Outpatient
10%
Systematic Review
9%
Lung Cancer
8%
Cerebrospinal Fluid
8%
Pneumococcal Infection
8%
Pulmonary Rehabilitation
8%
Intensive Care Unit
8%
Malignant Neoplasm
7%
Chronic Hepatitis C
7%
Odds Ratio
7%
Diagnosis
7%
Pathogen
7%
C Reactive Protein
7%
All Cause Mortality
7%
Smoking
6%
Transplantation
6%
Placebo
6%
Brain Abscess
6%
Asthma
6%
QuantiFERON
6%
Low Drug Dose
6%
Central Nervous System Infection
5%
Mortality Rate
5%
Health Care
5%
Proportional Hazards Model
5%
Lung Cancer Screening
5%
Population
5%
Interferon
5%
Serotype
5%
Hepatitis C Virus
5%
Leukocyte
5%
Wart Virus
5%
Acute Exacerbation of Chronic Obstructive Pulmonary Disease
5%
Diabetes Mellitus
5%
Chronic Hepatitis B
5%
Adiponectin
5%
Clinician
5%
Artificial Respiration
5%
Interferon Gamma Release Assay
5%
Release Assay
5%
Bronchiectasis
5%
Patient Experience
5%
Cohort Effect
5%
Immunoglobulin
5%
Intervertebral Disk Degeneration
5%